Serum Prolidase Activity and the Role of Leptin in Osteomalacia (NCT05716750) | Clinical Trial Compass
UnknownNot Applicable
Serum Prolidase Activity and the Role of Leptin in Osteomalacia
38 participantsStarted 2023-02-15
Plain-language summary
Evaluation of the change of serum Prolidase and Leptin values in the diagnosis and follow-up of osteomalacia and its clinical usability
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Among the patients who applied to the outpatient clinic, those with clinical complaints of osteomalacia (diffuse pain, fatigue, rapid fatigue, proximal extremity weakness, etc.)
* 25 0H vit. D level of 10ng/ml and below
Exclusion Criteria:
* Other metabolic and endocrine bone diseases (secondary osteoporosis, paget hast, osteogenesis imperfecta, osteomyelitis etc.)
* Patients who have previously received treatment for low vitamin d
* Those with low vitamin D levels due to liver or kidney failure
* Those who receive treatment for tumor